Bayesian Capital Management, LP - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 459 filers reported holding REPLIGEN CORP in Q1 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
Bayesian Capital Management, LP ownership history of REPLIGEN CORP
ValueSharesWeighting
Q1 2023$933,051
+10.8%
5,542
+11.4%
0.12%
-6.5%
Q4 2022$842,317
+258.4%
4,975
+461.5%
0.12%
+66.2%
Q4 2021$235,000
-59.7%
886
-70.5%
0.07%
-44.8%
Q1 2021$583,000
-40.3%
3,000
-41.2%
0.13%
-47.5%
Q4 2020$977,000
+328.5%
5,100
-19.2%
0.26%
+339.7%
Q1 2018$228,0006,3130.06%
Other shareholders
REPLIGEN CORP shareholders Q1 2021
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders